Efficacy and Safety of Fixed Combination Foster in Asthma Patients in Real Clinical Practice
In this prospective noncomparative open multicenter observational 12weeks study 697 patients with moderate asthma were enrolled. All patient received Foster. Primary endpoint was the level of asthma control. 140 patients were excluded from efficacy analysis. Overall the level of asthma control was improved in 99.6% patients. 25.7% from 425 patients with uncontrolled asthma have obtained partly controlled asthma, 74.1% have obtained full con trol. 89.3% from 122 patients with partly controlled asthma have obtained full control and 9.8% retain partly con trolled asthma. The study confirmed therapeutic equivalency of Foster to other fixed combinations with higher doses of glucocorticosteroids.